C/C(=N\N=C(N)N)c1sc(-c2nc(C)c(/C(C)=N/N=C(N)N)s2)nc1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?